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Background: It is well documented that cancer cells secrete angiogenic factors to recruit and sustain tumor
vascular networks. However, little is known about the effects of endothelial cells on the behavior of tumor cells.
The study here was to determine the roles of endothelial cells in HCC cell growth, migration and invasion.
Methods: A mixture of highly metastatic MHCC97H cells and HUVEC cells, as well as MHCC97H cells alone were
subcutaneously injected into nude mice to observe the effects of HUVECs on HCC growth. The biological
characteristics of MHCC97H cells respectively treated with conditioned medium (CM) derived from HUVECs and
endothelial cell basal medium (EBM) in vitro, such as proliferation, migration and invasion, invasion/metastasis
associated gene expression, were comparatively analyzed. Differential cytokines between CM and EBM were
screened and identified using human cytokine array. Effects of the interested differential cytokine CCL2, IL-8 and
CXCL16 and its related signaling pathways were further investigated in HCC cells.
Results: Subcutaneous tumorigenicity of MHCC97H cells in nude mice was promoted by HUVECs and its invasion/
metastasis associated genes were significantly upregulated. The in vitro, proliferation, migration and invasion of
HCC cells treated with CM were all significantly enhanced as compared to those with EBM stimulation.
Simultaneously, PI3K/Akt and ERK1/2 pathway in HCC cells were activated by CM. Total of 25 differential cytokines
were identified between CM and EBM such as angiopoietin-2, CCL2 (MCP-1), uPA, endostatin, CXCL16, IL-8,
pentraxin 3 etc. The selected differential cytokines CCL2, IL-8 and CXCL16 all modulated the expressions of HCC
invasion/metastasis genes, especially MMP2 and MMP9. In exposure to CCL2 or CXCL16 alone, upregulation in AKT
phosphorylation but no change in ERK phosphorylation were found in MHCC97H cells, moreover the contents of
nuclear transcription factor NF-κB were increased as compared to the control. However, no effects on the activation
of Akt and ERK pathway in MHCC97H were found in exposure to IL-8.
Conclusion: This study expands the contribution of endothelial cells to the progression of HCC. It unveils a new
paradigm in which endothelial cells function as initiators of molecular crosstalks that enhance survival, migration
and invasion of HCC cells.
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Hepatocellular carcinoma (HCC) is the fifth most com-
mon cancer worldwide and the third leading cause of
cancer-related death [1]. Although significant advances
in surgical techniques and perioperative care over the
last two decades, the long-term prognosis of HCC re-
mains dismal largely due to the high frequency of metas-
tasis or recurrence. Recently, more evidences suggest
that HCC metastasis involves a complex cascade of sig-
nal events between tumor cells and host stroma micro-
environment. These crosstalking might modulate or
determine the process of HCC invasion and metastasis.
Thus, exclusive reliance on tumor cell itself for research
cannot enable insight into the diverse pathological
changes occurring in HCC metastasis. Generally, the
microenvironment of HCC is composed of stromal cells
(e.g., hepatic stellate cells, fibroblasts, invading inflam-
matory/immune cells, and endothelial cells) and non-
cellular components (e.g., growth factors, proteolytic
enzymes, inflammatory cytokines, and extensive extra-
cellular matrix proteins). A lot of studies on HCC have
validated the important roles of stromal cells in HCC
progression [2]. Hepatic stellate cells (HSCs) increase
HCC growth and invasion both in vitro and in vivo.
Conditioned media derived from HSCs induce HCC cell
proliferation and migration. Moreover, on a three-
dimensional spheroid co-culture system as well as an
in vivo implantation of a mixture of HSCs and HCC
cells, HSCs obviously accelerate HCC growth and dimin-
ish the extent of central necrosis [3,4]. Activated HSCs
also enhance HCC progression by other means such as
regulating T cells that create an immunosuppressive
microenvironment and stimulating angiogenesis [5].
Through the release of different factors like cytokines,
chemokines, or enzymes, tumor-associated macrophages
(TAMs) can regulate tumor growth, angiogenesis, inva-
sion, and metastasis [6]. Particularly, some secreted fac-
tors from TAMs also induce cancer cell motility, thereby
enhancing tumor cell invasion capacity [7]. These data
demonstrate that stromal cells can actively modulate the
malignant characteristics of HCC cells and further deter-
mine the outcome of HCC.
Given that tumors have abundant blood vessels for sup-
plying oxygen and nutrition, endothelial cells (ECs) are
ubiquitous within solid tumors. In other solid tumors, ECs
modulate various pathophysiological processes [8,9]; in
HCC, ECs directly influence cancer progression through
neoangiogenesis [10]. However, the molecular framework
of this crosstalk in the context of a specific tissue and its
consequences on HCC metastasis are largely unknown.
Thus, the counteractive effects of ECs on HCC cell behav-
iors in cancer development and progression merit to be
investigated. In this study, we provided some evidences
that EC-initiated signaling directly affected the malignantprogression of HCC cells in vitro and in vivo, and that the
induction of PI3K/Akt and NF-κB activation may be re-
sponsible for these effects.
Materials and methods
Cell lines and animals
The MHCC97H cells (established in the Liver Cancer
Institute of Fudan University [11]) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Gibco)
supplemented with 10% fetal bovine serum (FBS, Gibco).
Human Umbilical Vein Endothelial Cells (HUVECs,
ScienCell) were cultured in EC basal medium (EBM;
ScienCell) with additional 10% FBS, and guaranteed to
subcultured for three population doublings. Male BALB/c
nu/nu mice (3-4 week old; SLAC Laboratory Animal Co,
Ltd, Shanghai, China) were housed in specific pathogen-
free conditions. All animal protocols were approved by the
Ethical Committee on Animal Experiments of the Univer-
sity of Fudan Animal Care Committee, Shanghai, China
(Permit Number: SYXK:2008-0039). All efforts were made
to minimize suffering.
Collection of conditioned medium (CM) from HUVECs
After HUVEC growth in a T75 flask reached approxi-
mately 80% confluency, the medium was changed with
complete endothelial cell basal medium (EBM) containing
10% FBS (20 mL/T75) and incubated for 24 h. The same
medium was incubated for 24 h in a T75 flask without
HUVECs to serve as a control. The collected superna-
tant was concentrated by a centrifugal filter (Millipore,
Schwalbach, Germany) at 4000 rpm for 30 min at 4°C.
The concentrated supernatant was then filtered through
0.2 μm filters and stored at −80°C for further use. The
protein concentration of the concentrated supernatant
was measured by BCA protein assay (Pierce).
Subcutaneous tumorigenicity test of MHCC97H cells
premixed with HUVECs
Nude mice were subcutaneously injected at the upper
left flank region with 0.1 mL of cell suspension contai-
ning either 5 × 106 MHCC97H cells or a mixture of
5 × 106 MHCC97H cells and 1 × 106 HUVECs. Tumor
growth was evaluated by measuring the length and width
of tumor mass at the inoculation site. After 10 days, the
tumor-bearing mice were sacrificed. The tumors were
removed and fixed in 4% formaldehyde for pathological
analysis and snap frozen in liquid nitrogen for gene
expression analysis.
Cell proliferation assay
About 100 μl of MHCC97H cells (6 × 103 cells) with
DMEM containing 10% FBS were seeded into a 96-well
plate. At the indicated time points, 10 μl of CCK-8
solution (Dojindo, Japan) was added to the cells and
Table 1 Primer pairs used for qRT-PCR











qRT-PCR quantitative real time reverse transcription polymerase chain reaction,
F forward, R reverse.
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well was tested by color absorbance at 450 nm.
Wound healing assay, cell invasion assay, and cell motility
assay
Scratch wound healing assay was performed to assess
cell migration. In brief, 3 × 104 MHCC97H cells were
cultured in a 24-well plate for 24 h. After a tight cell
monolayer was formed, the cells were incubated with
serum-free medium for 24 h and the cell monolayer was
wounded with a plastic pipette tip. The remaining cells
were washed twice with fresh medium to remove cell deb-
ris, and further incubated with CM or EBM for 24 and
48 h. At the indicated time points, the migrant cells at the
wound front were photographed with a microscope.
The cell invasive assay was the same as in our previous
study with minor modifications [12]. Briefly, 1 × 105
MHCC97H cells in 100 μl of serum-free DMEM were
placed into the upper compartment of a boyden cham-
ber (Costar) precoated with Matrigel, and 600 μl defined
medium containing CM or EBM was added to the lower
compartment as a chemoattractant. After incubating for
48 h, the cells that failed to penetrate the filters were
gently removed by cotton swabs. The invading cells in
the membrane were fixed with 4% formaldehyde in PBS
(Gibco), stained in Giemsa for 10 min, and then counted
under a light microscope. Cell motility assay was
performed similarly except that an uncoated filter was
used and the incubation time was 18 h.
Quantitative reverse transcription polymerase chain
reaction (qRT-PCR)
Total RNA from cells was extracted using Trizol reagent
(Invitrogen, Karlsruhe, Germany) according to the man-
ufacturer’s protocol. The complementary DNA (cDNA)
was synthesized using the Superscript First-Strand Syn-
thesis System (Thermo Scientific, Epsom, UK) and used
as template for RT-PCR with a gene specific primer and
SYBR Green PCR Master Mix kit (Invitrogen, Karlsruhe,
Germany). Relative gene expression was normalized to
GAPDH and reported as 2-ΔCt [ΔCt = Ct (MMP2 or
other gene)-Ct (GAPDH)]. The primer sequences of
matrix metalloproteinase 2 (MMP2), MMP9, CD44, and
osteopontin (OPN) are listed in Table 1.
Western blot analysis
Protein extraction and Western blot analysis were
performed as in our previous work [13]. Primary anti-
bodies were diluted with TBSA as follows: p-Akt
(Ser473, 1:1000; Cell Signaling Technology, Boston,
USA), Akt (1:1000; Cell Signaling Technology, Boston,
USA), p-ERK (Thr202/Tyr204, 1:1000; Cell Signaling
Technology, Boston, USA), ERK (1:1000; Cell Signaling
Technology, Boston, USA), and GAPDH (1:1000;Kangchen). Secondary antibodies were diluted with
TBSA (against mouse and rabbit, 1:5000; Dingguo Bio,
Beijing, China).
Immunohistochemistry and immunocytochemical assays
Immunohistochemical staining was performed based on
the method of Tang [14]. In a typical procedure, after
rehydration and antigen retrieval, cell slides were incu-
bated with diluted primary antibody against human
p-Akt (1:50; Cell Signaling Technology, Boston, USA)
and p-ERK (1:50; Cell Signaling Technology, Boston,
USA) at 4°C overnight, followed by the secondary anti-
body conjugated with HRP (anti rabbit, 1:200; Dingguo
Bio Beijing, China) at 37°C for 30 min. Staining was car-
ried out with 3,3′-diaminobenzidine (DAB) and counter-
staining was conducted with Mayer’s hematoxylin. Cell
immunocytochemical assay was performed similar to the
above method except for the cell coverslip preparation
and fixation, as well as the use of primary antibodies
against Ki67 (1:100; Dako, Copenhagen, Denmark),
MMP2 (1:100; Santa Cruz Biotechnology, Heidelberg,
Germany), and MMP9 (1:100; Cell Signal Technology,
Boston, USA).
Human cytokine array
Angiogenesis-related protein expression in CM and EBM
was evaluated by a semiquantitative technique (Proteome
Profiler™, Human Angiogenesis Array Kit, R&D Systems,
Minneapolis, USA) according to the manufacturer’s in-
structions. The selected capture antibodies were spotted in
duplicate on nitrocellulose membranes. Samples were di-
luted and mixed with a cocktail of biotinylated detection
antibodies. The sample/antibody mixture was then incu-
bated with a Human Angiogenesis Array kit. Any protein/
detection antibody complex present was bound by its
cognate-immobilized capture antibody on the membrane.
After washing to remove unbound materials, streptavidin-
HRP and chemiluminescent detection reagents were
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portion to the amount of bound analyte. Data were cap-
tured by exposure to X-ray films. Array signals from the
scanned X-ray film images were analyzed using Image J.
The results were expressed as fold changes above or below
the unexposed cultures.
Evaluation of nuclear factor-κB (NF-κB) DNA binding
activity
The nuclear extracts and DNA-binding activity of NF-
κB in MHCC97H cells were prepared according to the
instruction of Active Motif. Briefly, after treating HCC
cells with cytokine CCL2 (chemokine C-C motif ligand
2, R&D Systems, Minneapolis, USA), IL-8 (interleukin-8,
Sigma, Tokyo, Japan), and CXCL16 (chemokine C-X-C
motif ligand 16, R&D Systems, Minneapolis, USA) for
24 h, MHCC97H cells were collected in ice-cold PBS
with phosphate inhibitors and centrifuged at 500 rpm
for 5 min. The pellets were resuspended and treated
with a detergent. After removing the cytoplasmic frac-
tion by centrifugation at 14 000 × g for 30 s, nuclei were
harvested and lysed in lysis buffer with the protease in-
hibitor cocktail for nuclear protein extraction.
The content of NF-κB binding to DNA in nuclear ex-
tracts was measured using specific TransAM NF-κB p65
assay (active motif ). A 96-well plate was precoated with
an oligonucleotide containing the NF-κB p65 binding
consensus site. The active form of the p65 subunit was
detected using antibodies specific for an epitope that
was accessible only when the appropriate subunit bound
to its target DNA. An HRP-conjugated secondary anti-
body provided a colorimetric readout that was quantified
by a spectrophotometer (450 nm).
Statistical analysis
Data were analyzed using SPSS software (version 16.0).
Results were expressed as the mean ± SD. Statistical ana-
lysis was performed by one-way ANOVA and Student’s
t-test. P < 0.05 was considered statistically significant.
Results
Effects of HUVECs on the tumorigenicity of MHCC97H
cells in vivo
To assess the effects of HUVECs on the tumorigenicity
of HCC cells, we injected subcutaneously MHCC97H
cells into nude mice either alone or in combination with
HUVECs. Subcutaneous tumors developed at the site of
implantation in mice. The tumor size in mice implanted
with a mixture of HUVECs and MHCC97H cells were
much larger than that in mice implanted with
MHCC97H cells alone (Figure 1A). In addition, the ex-
pression of HCC invasion/metastasis-associated genes
(MMP2, MMP9, OPN, and CD44) in the subcutaneous
mixed tumor of MHCC97H cells and HUVECs weresignificantly higher than those formed by MHCC97H
cells alone (*p < 0.05; Figure 1B).
Changes in the malignant properties of HCC cells under
CM stimulation
As shown in Figure 2A and B, the proliferation of HCC
cells treated with CM derived from HUVECs significantly
increased compared with that treated with EBM (*p <
0.05). The numbers of nuclear Ki67-positive cells in the
MHCC97H cells treated with CM also increased. These
results supported that some secreted factors derived from
HUVECs may stimulate HCC cell proliferation in vitro.
Wound healing assay revealed that the amount of
migrating cells at the wound front were much higher
than that of the control (Figure 2C). It suggested that
the migratory capability of HCC cells can be significantly
enhanced by CM from HUVECs. Cell motility assay
demonstrated that under induction by CM, the average
number of MHCC97H cells (34.9 ± 2.3) that penetrated
the filters increased compared with induction by EBM
(19.0 ± 3.6; Figure 2D).
The numbers of invading MHCC97H cells induced by
CM (13.4 ± 1.5) were obviously higher than those
induced by EBM (5.7 ± 1.2) in cell invasion assay.
(Figure 2D). On the other hand, the expression of
MMP2, MMP9, OPN, and CD44 were also remarkably
upregulated in MHCC97H cells treated with CM
compared with those treated with EBM (Figure 2E).
Moreover, high expression of MMP2 and MMP9 was
confirmed using immunofluorescent staining (Figure 2F).
Combined with the aforementioned results of cell migra-
tion, the distinct increase in cell invasion ability under
CM stimulation can be associated with the enhanced cell
motility and upregulation of MMPs.
CM induced the activation of the PI3K/Akt and ERK
pathways in HCC cells
Activation of the PI3K/Akt and ERK pathways by CM is
reportedly involved in regulating the invasion and me-
tastasis in HCC cells [15]. In the present study, the levels
of Akt and ERK phosphorylation in MHCC97H cells
under CM stimulation were elevated compared with that
in the control cells (Figure 3A). High expression of
phosphorylated Akt and phosphorylated ERK was also
found in subcutaneous tumor formed by MHCC97H
cells premixed with HUVECs compared with that
formed by MHCC97H cells alone (Figure 3B). These
data verified that CM induced the activation of the
PI3K/Akt and ERK pathways in HCC cells.
Screening of the content of differential cytokines
between CM and EBM
A human cytokine array (Figure 4A) comprising 55
different cytokines was used to screen the content of
Figure 1 Subcutaneous tumorigenicity test of MHCC97H cells premixed with HUVECs and the expression of HCC invasion/metastasis-
associated genes. (A) MHCC97H cells as well as a mixture of MHCC97H cells and HUVECs were subcutaneously implanted into nude mice as
described in the “Material and methods” section. Representative tumors resected from nude mice appeared 10 days after implantation. (B) The
expression of MMP2, MMP9, OPN, and CD44 were detected by qRT-PCR in subcutaneous tumors (*P < 0.05, **P < 0.01, ***P < 0.001 vs. MHCC97H
cells alone).
Wang et al. Journal of Experimental & Clinical Cancer Research 2013, 32:51 Page 5 of 11
http://www.jeccr.com/content/32/1/51differential stimulatory factors between CM and EBM. A
total of 25 differential cytokines were found in CM
(Figure 4B and Table 2). Among them, 22 were upregu-
lated [angiopoietin-2, angiogenin, IGFBP-2, IGFBP-3,
CCL2 (also known as monocyte chemoattractant protein-
1, MCP-1), IGFBP-1, MMP-9, uPA, endostatin, CXCL16,
endothelin-1, IL-8, TIMP-1, etc.] and 3 were downregu-
lated (pentraxin 3, serpin E1, and VEGF). Some factors
among the identified differential factors may be involved
in the regulation of HCC cell growth, migration, and
invasion as the results mentioned above.
CCL2, IL-8, and CXCL16 regulated the expression of
invasion- and metastasis-associated genes
Three primary cytokines of interest (CCL2, IL-8, and
CXCL16) were selected to explore their biological effects
on HCC cell invasion and metastasis. The expressions of
MMP2, MMP9, OPN, and CD44 genes were upregulated
in MHCC97H cells following CCL2, IL-8, or CXCL16
stimulation, but had no obvious dose-dependent effect
(Figure 5). It indicated that CCL2, IL-8, and CXCL16
stimulated the high expressions of invasion/metastasis
associated genes, and further changed the invasion abil-
ity of HCC cells.
Effects of CCL2, IL-8, or CXCL16 on the activation of the
PI3K/Akt, ERK, and NF-κB pathways in HCC cells
As shown in Figure 3, CM increased the activation of
the PI3K/Akt and ERK signaling pathways in HCC cells.
Accordingly, we next determined whether the differen-
tial cytokines CCL2, IL-8, and CXCL16 identified from
CM had similar effects on the invasion ability of HCC
cells by activating the PI3K/Akt and ERK pathways.
After exposure to CCL2 or CXCL16 alone, the AKTphosphorylation level significantly increased in MHCC9-
7H cells, but the ERK phosphorylation level had no
change. Additionally, no effects were found on the acti-
vation of the Akt and ERK pathways after exposure to
IL-8 (Figure 6A). However, the contents of NF-κB all in-
creased compared with that of the control under CCL2,
IL-8 or CXCL16 stimulation alone (Figure 6B).
Discussion
Stroma cells in a tumor microenvironment contribute to
the stimulation or modulation of the aggressive behavior
of tumor cells. However, to date, the effects of ECs on
the malignant biological characteristics of HCC cells are
poorly understood. Blood vessel formation and neoan-
giogenesis are essential to the biological function of ECs.
Pro-angiogenic factors secreted from HCC cells such as
VEGF, EGF, PDGF, etc. attract various types of ECs from
adjacent nontumorous tissues, circulating ECs, or bone
marrow-derived endothelial progenitor cells to the site
where neoangiogenesis occurs [16]. Meanwhile, ECs iso-
lated from HCC tissue increase the angiogenesis activity
with higher resistance to chemotherapeutic agents and
inhibitors of angiogenesis [17], and are associated with a
high risk for metastasis [18]. In breast cancer, ECs pro-
mote tumor cell growth, invasion/metastasis, and the
aggressive phenotype [8,19]. In head and neck squamous
cell carcinoma, crosstalk initiated by ECs facilitates
tumor cell growth, migration, and invasion [9,20].
However, in lung and breast cancers, quiescent HUVEC-
conditioned media suppress cell proliferation and
invasion [21]. Our study suggested a new paradigm in
which EC-initiated signaling directly affects the malig-
nant progression of HCC cells. The HUVECs promoted
the tumorigenicity of MHCC97H cells in nude mice and
Figure 2 (See legend on next page.)
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Figure 2 Changes in the malignant properties of HCC cells under CM stimulation. (A) CM significantly promoted HCC cell proliferation
(**P < 0.01 vs. EBM at 48 h) was measured by CCK8. (B) The expression of Ki67 in the nucleus of HCC cells. (C) Wound healing assays were
performed with MHCC97H cells incubated by CM or EBM. The amount of migrating cells at the wound front was much higher than that in the
control (**P < 0.01). (D) In the cell motility/invasion assay, the average numbers of penetrating HCC cells induced by CM were all obviously higher
than those induced by EBM (***P < 0.001). (E) CM significantly increased the expression of HCC invasion/metastasis-associated genes in HCC cells
compared with EBM (*P < 0.05). (F) High expression of MMP9 and MMP2 were confirmed in MHCC97H cells by immunofluores-
cent staining.
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metastasis-associated genes (MMP2, MMP9, OPN, and
CD44). In vitro, CM from HUVECs significantly increased
the proliferation of MHCC97H cells, and induced higher
expression of MMP2, MMP9, OPN, and CD44 compared
with the control medium. Moreover, CM increased the
migration and invasion ability of MHCC97H cells
(Figures 2C and 2D). These data indicated that HUVECs
may participate in regulating tumor growth and invasion
through the secreted soluble factors.
Angiogenesis Profiler Array was used here to screen
different factors that mediated these effects between
tumor cells treated with CM and EBM. A total of 25
differential cytokines were identified, including 22
upregulated and 3 downregulated cytokines in CM.
Among them, CCL2, IL-8, and CXCL16 were selected
for further biological function exploration based on the
following reasons (1) CCL2 was the leading upregulated
cytokine in CM but not in EBM. CXCL16 was a moder-
ately upregulated cytokine in CM and had a trace con-
tent in EBM. (2) IL8 was a slightly upregulated cytokine
in CM but had high contents in CM and EBM. (3) The
role of EC-secreted CCL2, IL-8, and CXCL16 in the
biological functions of HCC invasion and metastasis is
largely unknown.
To clarify the biological effects of CCL2, IL-8, and
CXCL16 on HCC cell invasion, we exposed these cells
to CCL2, IL-8, and CXCL16 at different concentrations,Figure 3 Effects of CM on PI3K/Akt and ERK pathway activation in HC
CM or EBM stimulation were detected by Western blot. (B) Expression of p
MHCC97H cells and HUVECs were analyzed by immunohistochemistry.respectively. The MMP2, MMP9, OPN, and CD44 genes
highly expressed in MHCC97H cells under CCL2, IL-8
or CXCL16 stimulation alone like CM stimulation. It in-
dicated that CCL2, IL-8, and CXCL16 stimulation
upregulated the expressions of invasion/metastasis asso-
ciated genes, and further changed the invasion ability of
HCC cells. Other studies also favor the significance of
cytokine CCL2 in invasiveness and migration of tumor
cells such as prostate cancer cells [22,23], breast cancer
cells [24] etc. In addition, myofibroblasts-secreted CCL2
also enhances the malignant phenotypes of HCC cells by
upregulating MMP2 and MMP9 expression [25], all
signs as mentioned above suggest CCL2 involves in
pathological development of tumor. However, the se-
creted CCL2 from ECs influencing HCC cells are little
known. CXCL16 and CXCR6 levels increase as tumor
malignancy increases in some literatures [26-30]. Soluble
CXCL16 chemokine induces proliferation and migration
of cancer cells, further regulates invasion and metastasis
of cancer [28,30]. In eight hepatoma cells, CXCR6 and
its ligand CXCL16 are consistently expressed, and ele-
vated expression of CXCR6 promotes HCC invasiveness
and is associated with poor outcomes of patients [31].
These data show CXCL16 stimulation may change the
malignant phenotype of HCC cells. The crucial roles of
the secreted IL-8 from cancer cells have been validated
in tumor growth, angiogenesis, and invasion/metastasis
[32-36], and high IL-8 expression is correlated withC cells. (A) Expression of p-Akt and p-ERK in MHCC97H cells under
-Akt and p-ERK in subcutaneous tumors derived from a mixture of
Figure 4 Profile analysis of differentially expressed cytokines. (A) Screening of different cytokines using a human cytokine array between
CM (top panel) and EBM (bottom panel). (B) A total of 25 differentially expressed cytokines were expressed as fold changes above or below
the control.
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duce the upregulation of MMP7 but has no effects on
MMP2 and MMP9 expression in HepG2 cells [39]. On
the contrary, in this study, IL-8 stimulation resulted in
high expression of MMP2 and MMP9 in MHCC97H
cells in a dose-dependent manner (Figure 5B), which
might attribute to different malignant phenotypes of
MHCC97H and HepG2 cells.
Increased PI3K/Akt and ERK activation reportedly in-
duces the proliferation of HCC cells, prevents HCC cell
apoptosis [40], changes the migratory activity and inva-
siveness of HCC cells [41,42], and is an independent
prognostic index for HCC patients [43]. Activation of
the PI3K/Akt pathway can enhance MMP2 and MMP-9
expression in HCC and further regulate HCC cell inva-
sion [44,45]. Tumor stromal cells also influence HCC
cell invasion ability by activating the PI3K/Akt and ERK
pathways [3,25]. In head and neck squamous cell
carcinoma, the secreted factors from ECs promote cell
migration and invasion by activating the Akt and ERK
Figure 5 Regulation of the expression of HCC invasion/metastasis-associated genes by CCL2, IL-8, and CXCL16 in HCC cells. CCL2 (A),
IL-8 (B), and CXCL16 (C) induced MMP2, MMP9, OPN, and CD44 expression in MHCC97H cells (*P < 0.05, **P < 0.01, ***P < 0.001 vs. the control).
Figure 6 Effects of CCL2, IL-8, and CXCL16 on the activation of the Akt, ERK, and NF-κB pathways in HCC cells. The levels of
phosphorylated Akt and ERK in MHCC97H (A) Cells after exposure to CCL2, IL-8, or CXCL16 at different concentrations. (B) Activation of NF-κB in
MHCC97H cells were measured using a specific TransAM NF-κB p65 kit under CCL2, IL-8, or CXCL16 stimulation (*P < 0.05 vs. the control).
(C) Schematic drawing illustrating the proposed mechanism by which endothelial cell-derived cytokines initiated a paracrine signaling cascade
that results in enhanced HCC growth and invasion.
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cient RFA stimulates EC secretion of IL-6, IL-8, and
CCL2 to activate the Akt, ERK, and NF-κB pathways,
and further promotes the invasion of HCC cells [15].
Our data suggested that CM from HUVECs enhanced
HCC cell migration and invasion, as well as up-
regulated HCC invasion/metastasis gene expression
in vivo and in vitro. CM also upregulated the phosphor-
ylation levels of Akt and ERK in HCC cells in vivo.
These results clearly indicated that CM activating the
PI3K/Akt and ERK pathways, as one of the complex
signal events, may be involved in the regulation of HCC
invasion and metastasis. CCL2, IL-8, and CXCL16, the
identified differential cytokines from CM, modulated the
expression of HCC invasion/metastasis genes, especially
MMP2 and MMP9. CCL2 or CXCL16 alone stimulated
significantly the upregulation of phosphorylated AKT in
MHCC97H cells, but had no change in ERK phosphoryl-
ation. CCL2 or CXCL16 alone also increased the
contents of NF-κB compared with the control. These
findings hinted that the released CCL2 or CXCL16 from
HUVECs may be responsible for HCC cell migration
and invasion by increasing MMP2 and MMP9 produc-
tion through the PI3K/Akt pathway. Other studies on
Huh7 cells and chondrosarcoma cells have also revealed
a similar molecular mechanism in which CCL2 regulates
MMP2 and MMP9 expression through the PI3K/Akt
and NF-κB signaling pathways [25,46]. In prostate can-
cer cells [47], a CXCR6/CXCL16 pair may activate the
PI3K/Akt signal pathway. Surprisingly, although IL-8
upregulated the expression of HCC invasion/metastasis
genes and increased the contents of NF-κB, it did not
affect the activation of the Akt and ERK pathways in
MHCC97H. NF-κB is an inducible transcription factor
for MMP2 and MMP9 expression in some literatures
[46,48,49]. We speculate that IL-8 may activate NF-κB
through other signal pathways to regulate the expression
of MMP2 and MMP9.
Here, we also mention that the used human cytokine
array in the study belongs to a functional protein chip
with limited number of cytokine antibodies on it, which
is not able to cover all released cytokines from HUVECs.
Accordingly, except for 25 identified differential cyto-
kines, the other unidentified cytokines derived from
ECs still deserve to be further investigated in the follo-
wing study.
In summary, several secreted factors from ECs directly
influenced HCC cell proliferation, migration, and inva-
siveness. The differential cytokines CCL2 and CXCL16
identified in CM may be involved in HCC invasion and
metastasis by activating the PI3K/Akt and NF-κB signal-
ing pathways. IL-8 may activate NF-κB through other
signal pathways to regulate the expression of MMP2
and MMP9 (Figure 6C). Further studies are needed toidentify and characterize the signaling events initiated by
ECs for future implication in cancer therapy.
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